Home | News and Developments | Diabetes Newsletter | trial

Insulin Resistance Intervention After Stroke Trial

Conditions

Diabetes | Myocardial Infarction | Stroke

What is the purpose of this trial?

The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.


Participation Guidelines

Age:
40 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.

Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Takeda Pharmaceuticals North America, Inc.
Yale University
Dates:
February 2005
Last Updated:
August 3, 2011
Study HIC#:
0201013034

Clinicaltrials.gov ID: NCT00091949